Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Pranlukast and mirabegron may work as new diabetes drugs.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

These new skin treatments are safer and more effective with minimal side effects.

Danthron from Rhubarb causes melanoma cells to stop growing and die.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Vitamin D receptor helps prevent skin tumors.

The new delivery method for dutasteride is more effective and has fewer side effects.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Baricitinib is effective for severe alopecia areata but has some side effects.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.